readthroughSign in
CompanyVIRNasdaqSan Francisco, CA

Vir Biotechnology, Inc.

Vir Biotechnology develops immunotherapies for infectious diseases and cancer.

424B5Nov 16Latest SEC filing
Nov 16Latest story